Rational discovery of novel nuclear hormone receptor antagonists

AUTOR(ES)

Schapira, Matthieu

FONTE

The National Academy of Sciences

RESUMO

Nuclear hormone receptors (NRs) are potential targets for therapeutic approaches to many clinical conditions, including cancer, diabetes, and neurological diseases. The crystal structure of the ligand binding domain of agonist-bound NRs enables the design of compounds with agonist activity. However, with the exception of the human estrogen receptor-α, the lack of antagonist-bound “inactive” receptor structures hinders the rational design of receptor antagonists. In this study, we present a strategy for designing such antagonists. We constructed a model of the inactive conformation of human retinoic acid receptor-α by using information derived from antagonist-bound estrogen receptor-α and applied a computer-based virtual screening algorithm to identify retinoic acid receptor antagonists. Thus, the currently available crystal structures of NRs may be used for the rational design of antagonists, which could lead to the development of novel drugs for a variety of diseases.

Documentos Relacionados

• Discovery of diverse thyroid hormone receptor antagonists by high-throughput docking
• Rational design of receptor-specific variants of human growth hormone.
• Dissection of the LXXLL Nuclear Receptor-Coactivator Interaction Motif Using Combinatorial Peptide Libraries: Discovery of Peptide Antagonists of Estrogen Receptors α and β
• In silico discovery of novel Retinoic Acid Receptor agonist structures
• Antitumorigenic actions of growth hormone-releasing hormone antagonists